1Sarcoidosis and cancer risk: Systematic review and meta-analysis of observational studiesChest  Evidence Based Medicine
2Inflammatory markers and mortality among US adults with obstructive lung functionRespirology  Clinical Article
3A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary diseaseRespiratory Medicine  Clinical Article
4Does active dissemination of evidence result in faster knowledge transfer than passive diffusion?: an analysis of trends of the management of pediatric asthma and croup in US emergency departments from 1995 to 2009Pediatric Emergency Care  Clinical Article
5A pilot study: Mindfulness meditation intervention in COPDInternational Journal of COPD  Full Text  Clinical Article
6Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthmaThe Journal of Allergy and Clinical Immunology  Clinical Article
7Fluticasone furoate/vilanterol dry-powder inhaler: a guide to its use in chronic obstructive pulmonary diseaseDrugs & Therapy Perspectives  Clinical Article
8Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibilityThe Journal of Allergy and Clinical Immunology  Clinical Article
9New therapeutic options for noncystic fibrosis bronchiectasisCurrent Opinion in Infectious Diseases
10Significant correlation between urinary N1, N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancerBMC Cancer  Full Text  Clinical Article
1Medical nanoparticles: Local treatment of lung cancerHelmholtz Zentrum M√ľnchen - German Research Center for Environmental Health News
2FDA expands approved use of Opdivo to treat lung cancerFDA Press Announcements
3Lung screening guidelines improve on study findingsUniversity of Michigan Health System
4Bans don't help smokers quitConcordia University Research News
5Pregnant women with asthma need to curb urge to ask for antibioticsAmerican College of Allergy, Asthma and Immunology News
6Respiratory viruses are main childhood pneumonia culprit: StudyVanderbilt University Medical Center Research News
7New care model enhances psychological, cognitive and physical recovery of ICU survivorsIndiana University School of Medicine News
8Longer duration of prescribed antismoking medication before quitting appears promisingUniversity at Buffalo Health and Medicine News
9'Liquid biopsies' could help spot genetic faults in lung cancerCancer Research UK News
10Revised device labeling for the Cepheid Xpert MTB/RIF Assay assay for detecting mycobacterium tuberculosisMorbidity and Mortality Weekly Report

Show Me:

Lecithinized superoxide dismutase treatment promising in idiopathic interstitial pneumonia

As reported in BMC Pulmonary Medicine, lecithinized superoxide dismutase (80 mg x 28d) attenuated LDH and surfactant protein A levels in patients with progressive idiopathic interstitial pneumonia; there was no change in forced vital capacity. The LDH and surfactant protein levels returned to baseline by day 56. There were no differences between adverse events and mortality rates in the treated and placebo groups.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List